Edition:
India

Genprex Inc (GNPX.OQ)

GNPX.OQ on NASDAQ Stock Exchange Capital Market

3.73USD
8:36pm IST
Change (% chg)

$0.07 (+1.91%)
Prev Close
$3.66
Open
$3.72
Day's High
$3.78
Day's Low
$3.67
Volume
63,022
Avg. Vol
411,511
52-wk High
$7.03
52-wk Low
$0.23

Select another date:

Thu, Jun 25 2020

BRIEF-Genprex Receives USAN Approval Of Non-Proprietary Name For Lead Drug Candidate

* GENPREX RECEIVES USAN APPROVAL OF NON-PROPRIETARY NAME FOR LEAD DRUG CANDIDATE

BRIEF-Genprex Expands Manufacturing Program With Aldevron To Advance Oncoprex Clinical Development

* GENPREX EXPANDS MANUFACTURING PROGRAM WITH ALDEVRON TO ADVANCE ONCOPREX™ CLINICAL DEVELOPMENT

BRIEF-Genprex Files For Mixed Shelf Of Up To $200 Mln– SEC Filing

* GENPREX INC FILES FOR MIXED SHELF OF UP TO $200 MILLION – SEC FILING Source text: https://bit.ly/2UDD1xX Further company coverage:

BRIEF-Genprex Says Scheduled To Join Russell 3000 Index

* GENPREX SCHEDULED TO JOIN RUSSELL 3000® INDEX Source text for Eikon: Further company coverage:

BRIEF-Genprex Reports Receipt Of $2.5 Mln In Cash From Recent Warrant Exercises

* GENPREX ANNOUNCES RECEIPT OF $2.5 MILLION IN CASH FROM RECENT WARRANT EXERCISES

BRIEF-Genprex Enters Worldwide Patent, Technology License Agreement For Combination Of Its Tusc2 Gene Therapy With Immunotherapies

* GENPREX ENTERS INTO EXCLUSIVE WORLDWIDE PATENT AND TECHNOLOGY LICENSE AGREEMENT FOR COMBINATION OF ITS TUSC2 GENE THERAPY WITH IMMUNOTHERAPIES Source text for Eikon: Further company coverage:

BRIEF-Genprex Says David E. Friedman Resigned As A Member Of Board, Effective April 15

* GENPREX INC - DAVID E. FRIEDMAN RESIGNED AS A MEMBER OF BOARD EFFECTIVE AS OF APRIL 15, 2020 Source text: [https://bit.ly/3eK1R7U] Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Genprex Appoints Three New Members To Its Board Of Directors

* GENPREX INC - APPOINTMENT OF THREE NEW MEMBERS TO ITS BOARD OF DIRECTORS. Source text for Eikon: Further company coverage:

BRIEF-Genprex Inc Prices $17,500,000 Common Stock Offering Priced At-The-Market And Without Warrants

* GENPREX, INC. PRICES $17,500,000 COMMON STOCK OFFERING PRICED AT-THE-MARKET AND WITHOUT WARRANTS

Select another date: